Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$21.58 - $29.5 $129,177 - $176,587
-5,986 Reduced 35.52%
10,868 $293,000
Q3 2023

Nov 07, 2023

BUY
$25.8 - $39.97 $11,687 - $18,106
453 Added 2.76%
16,854 $499,000
Q2 2023

Aug 02, 2023

BUY
$20.94 - $38.01 $73,248 - $132,958
3,498 Added 27.11%
16,401 $587,000
Q1 2023

May 10, 2023

BUY
$22.92 - $33.76 $38,391 - $56,548
1,675 Added 14.92%
12,903 $302,000
Q4 2022

Feb 06, 2023

SELL
$25.44 - $59.78 $71,639 - $168,340
-2,816 Reduced 20.05%
11,228 $305,000
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $106,879 - $149,328
2,448 Added 21.11%
14,044 $756,000
Q2 2022

Aug 08, 2022

BUY
$28.82 - $77.35 $27,696 - $74,333
961 Added 9.04%
11,596 $468,000
Q1 2022

May 12, 2022

BUY
$48.25 - $100.49 $12,786 - $26,629
265 Added 2.56%
10,635 $705,000
Q4 2021

Feb 02, 2022

SELL
$88.71 - $120.43 $136,169 - $184,860
-1,535 Reduced 12.89%
10,370 $1.04 Million
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $14,815 - $19,825
-150 Reduced 1.24%
11,905 $1.49 Million
Q2 2021

Aug 03, 2021

SELL
$109.77 - $165.68 $114,819 - $173,301
-1,046 Reduced 7.98%
12,055 $1.5 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $90,198 - $127,161
710 Added 5.73%
13,101 $2 Million
Q4 2020

Feb 11, 2021

SELL
$99.96 - $135.93 $75,669 - $102,899
-757 Reduced 5.76%
12,391 $1.6 Million
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $23,694 - $32,981
-295 Reduced 2.19%
13,148 $1.47 Million
Q2 2020

Aug 11, 2020

BUY
$60.49 - $97.5 $60,248 - $97,110
996 Added 8.0%
13,443 $1.09 Million
Q1 2020

May 08, 2020

BUY
$59.04 - $88.81 $649,971 - $977,709
11,009 Added 765.58%
12,447 $866,000
Q4 2019

Feb 07, 2020

BUY
$59.49 - $82.78 $44,558 - $62,002
749 Added 108.71%
1,438 $113,000
Q3 2019

Oct 31, 2019

SELL
$62.59 - $110.3 $1,940 - $3,419
-31 Reduced 4.31%
689 $44,000
Q2 2019

Aug 09, 2019

BUY
$63.94 - $91.11 $46,036 - $65,599
720 New
720 $62,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.75B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.